Az mri helye a sclerosis multiplex kezelés hatékonyságának megítéléśeben II. Mérési protokollok

Zsigmond Tamás Kincses, Eszter Tóth, Zsanett Fricska-Nagy, Judit Füvesi, D. A.Cecilia Raj, K. Bencsik, E. Vörös, Angéla Csomor, András Palkó, L. Vécsei

Research output: Review article

1 Citation (Scopus)

Abstract

The paraclinical examinations, principally the MRI have an increasing significance in the diagnosis of multiple sclerosis. However, MRI markers also have a prominent role in monitoring of the disease-course and activity, and also in the planning of possible therapeutic changes. In accordance with previously published international guidelines, in this article we propose a protocol for the monitoring the treatment efficacy in multiple sclerosis. This could be the basis of a consensus based guideline to be implemented in Hungary.

Original languageHungarian
Pages (from-to)81-88
Number of pages8
JournalIdeggyogyaszati Szemle
Volume71
Issue number3-4
DOIs
Publication statusPublished - márc. 30 2018

Fingerprint

Multiple Sclerosis
Guidelines
Hungary
Therapeutics

Keywords

  • Biomarker
  • Guideline
  • MRI
  • Multiple sclerosis

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Az mri helye a sclerosis multiplex kezelés hatékonyságának megítéléśeben II. Mérési protokollok. / Kincses, Zsigmond Tamás; Tóth, Eszter; Fricska-Nagy, Zsanett; Füvesi, Judit; Raj, D. A.Cecilia; Bencsik, K.; Vörös, E.; Csomor, Angéla; Palkó, András; Vécsei, L.

In: Ideggyogyaszati Szemle, Vol. 71, No. 3-4, 30.03.2018, p. 81-88.

Research output: Review article

Kincses, Zsigmond Tamás ; Tóth, Eszter ; Fricska-Nagy, Zsanett ; Füvesi, Judit ; Raj, D. A.Cecilia ; Bencsik, K. ; Vörös, E. ; Csomor, Angéla ; Palkó, András ; Vécsei, L. / Az mri helye a sclerosis multiplex kezelés hatékonyságának megítéléśeben II. Mérési protokollok. In: Ideggyogyaszati Szemle. 2018 ; Vol. 71, No. 3-4. pp. 81-88.
@article{e31d23d802fc452ca2ed60cef789b578,
title = "Az mri helye a sclerosis multiplex kezel{\'e}s hat{\'e}konys{\'a}g{\'a}nak meg{\'i}t{\'e}l{\'e}śeben II.: M{\'e}r{\'e}si protokollok",
abstract = "The paraclinical examinations, principally the MRI have an increasing significance in the diagnosis of multiple sclerosis. However, MRI markers also have a prominent role in monitoring of the disease-course and activity, and also in the planning of possible therapeutic changes. In accordance with previously published international guidelines, in this article we propose a protocol for the monitoring the treatment efficacy in multiple sclerosis. This could be the basis of a consensus based guideline to be implemented in Hungary.",
keywords = "Biomarker, Guideline, MRI, Multiple sclerosis",
author = "Kincses, {Zsigmond Tam{\'a}s} and Eszter T{\'o}th and Zsanett Fricska-Nagy and Judit F{\"u}vesi and Raj, {D. A.Cecilia} and K. Bencsik and E. V{\"o}r{\"o}s and Ang{\'e}la Csomor and Andr{\'a}s Palk{\'o} and L. V{\'e}csei",
year = "2018",
month = "3",
day = "30",
doi = "10.18071/isz.71.0081",
language = "Hungarian",
volume = "71",
pages = "81--88",
journal = "Ideggyogyaszati Szemle",
issn = "0019-1442",
publisher = "Ifjusagi Lap-es Konyvkiado Vallalat",
number = "3-4",

}

TY - JOUR

T1 - Az mri helye a sclerosis multiplex kezelés hatékonyságának megítéléśeben II.

T2 - Mérési protokollok

AU - Kincses, Zsigmond Tamás

AU - Tóth, Eszter

AU - Fricska-Nagy, Zsanett

AU - Füvesi, Judit

AU - Raj, D. A.Cecilia

AU - Bencsik, K.

AU - Vörös, E.

AU - Csomor, Angéla

AU - Palkó, András

AU - Vécsei, L.

PY - 2018/3/30

Y1 - 2018/3/30

N2 - The paraclinical examinations, principally the MRI have an increasing significance in the diagnosis of multiple sclerosis. However, MRI markers also have a prominent role in monitoring of the disease-course and activity, and also in the planning of possible therapeutic changes. In accordance with previously published international guidelines, in this article we propose a protocol for the monitoring the treatment efficacy in multiple sclerosis. This could be the basis of a consensus based guideline to be implemented in Hungary.

AB - The paraclinical examinations, principally the MRI have an increasing significance in the diagnosis of multiple sclerosis. However, MRI markers also have a prominent role in monitoring of the disease-course and activity, and also in the planning of possible therapeutic changes. In accordance with previously published international guidelines, in this article we propose a protocol for the monitoring the treatment efficacy in multiple sclerosis. This could be the basis of a consensus based guideline to be implemented in Hungary.

KW - Biomarker

KW - Guideline

KW - MRI

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=85046104822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046104822&partnerID=8YFLogxK

U2 - 10.18071/isz.71.0081

DO - 10.18071/isz.71.0081

M3 - Review article

C2 - 29889466

AN - SCOPUS:85046104822

VL - 71

SP - 81

EP - 88

JO - Ideggyogyaszati Szemle

JF - Ideggyogyaszati Szemle

SN - 0019-1442

IS - 3-4

ER -